Therefore, this study aimed to investigate the predictive value of PD-L1 and TMB on the short-term efficacy of first-line treatment with ICIs in combination with chemotherapy in patients with locally advanced NSCLC and to provide a theoretical basis for the clinical development of individualized treatment. The gene discussed is CD274; the disease is non-small cell lung carcinoma.